In mammal species, arginine is a multifunctional amino acid required for survival, growth, and development of conceptuses (embryo/fetus and associated extraembryonic membranes) during the peri-implantation period of pregnancy. However, functional roles of arginine with respect to it being a substrate for production of nitric oxide (NO) and polyamines on trophectoderm cell proliferation and function remain largely unknown. To systematically assess roles of arginine in conceptus development and its effect on interferon tau (IFNT) production for pregnancy recognition signaling in ruminants, an established ovine trophectoderm (oTr1) cell line isolated from Day-15 ovine conceptuses were used to determine their response to arginine, putrescine, and NO donors, as well as their associated inhibitors. Arginine at physiological concentration (0.2 mM) stimulated maximum oTr cell proliferation (increased 2.0-fold at 48 h and 2.6-fold at 96 h; P , 0.05), stimulated IFNT production (IFNT/cell increased 3.1-fold; P , 0.05), and increased total protein per cell by more than 1.5-fold (P , 0.05). It also increased phosphorylated tuberous sclerosis protein (p-TSC2) and phosphorylated mechanistic target of rapamycin (MTOR) abundance by more than 2.7-and 4.3-fold (P , 0.0001) after long-term incubation, respectively. When Nx-nitro-L-arginine methyl ester hydrochloride (L-NAME; NO synthase inhibitor), DL-a-difluoromethylornithine hydrochloride hydrate (DFMO; ornithine decarboxylase inhibitor), and the combination (L-NAME + DFMO) were added, the effects of arginine on cell proliferation was reduced by 10.7%, 16.1%, and 22.3% (P , 0.05) at 48 h, and 15.3%, 27.2%, and 39.1% (P , 0.05) at 96 h of incubation, respectively, but values remained 1.5-fold higher (P , 0.05) than for the arginine-free control, which suggests that arginine, per se, serves as a growth factor. Both putrescine and NO stimulate cell proliferation via activation of the TSC2-MTOR signaling cascade, whereas only putrescine increased IFNT production. Collectively, our results indicate that arginine is essential for oTr1 cell proliferation and IFNT production via the NO/ polyamine-TSC2-MTOR signaling pathways, particularly the pathway involving polyamine biosynthesis.
INTRODUCTION
Peri-implantation embryonic mortality is the major constraint to improving reproductive performance as it accounts for 20%-40% of pregnancy failure in mammals [1] [2] [3] [4] . During this window of implantation, the conceptus (embryo/fetus and associated extraembryonic membranes) undergoes a rapid transition from spherical to tubular and filamentous forms that requires proliferation, migration, and cytoskeleton reorganization of trophectoderm cells, as well as transport or secretion of key nutrients (histotroph) into the uterine lumen, and conceptus-uterine interactions for pregnancy recognition signaling and implantation [1, 2] . The pregnancy recognition signals are interferon tau (IFNT) in ruminants, estrogens in pigs, placental lactogen or prolactin-like hormones in rodents, and chorionic gonadotrophin in primates. These pregnancy recognition signals produced by conceptus trophectoderm are required for maintenance of a functional corpus luteum on the ovary to secrete progesterone, the essential hormone of pregnancy that supports implantation, placentation, and uterine functions required for a successful pregnancy [1, 2, 5] . Histotroph, a complex mixture of molecules that are secreted by or transported into the uterine lumen by uterine luminal epithelia (LE), superficial glandular epithelia (sGE), and deeper glandular epithelia serve as the major sources of nutrients required for conceptus development [2, 6] .
Arginine is a conditionally essential amino acid for most mammals, including sheep [7, 8] . Concentrations of this nutrient in histotroph increase by 8-; 13-fold during the periimplantation period of pregnancy [9, 10] . Besides being a building block for protein synthesis, arginine is the common substrate for production of nitric oxide (NO) via NO synthases (NOSs) and for the biosynthesis of polyamines via arginase and ornithine decarboxylase (ODC1) [11] [12] [13] [14] [15] . The in vivo knockdown of arginine transporter, SLC7A1 mRNA, in ovine conceptus trophectoderm results in retarded development of conceptuses and a significant decrease in IFNT production [16] , whereas in vivo knockdown of NOS3 mRNA results in small, but elongated, conceptuses that produce normal amounts of IFNT [17] . A deficiency in polyamines (putrescine, spermidine, and spermine) results in failure of ovine conceptuses to elongate, and IFNT production is significantly reduced [18] . In rats and pigs, dietary arginine supplementation during early pregnancy enhances implantation and embryonic survival [19] [20] [21] . Similar results have been reported for mice in that arginine regulates trophoblast motility through mechanistic target of rapamycin (MTOR)-dependent and -independent pathways in the preimplantation blastocyst [22] . Furthermore, arginine administration has been reported to enhance fetal growth [23, 24] . However, there are no published reports of a systematic study of the functional roles of arginine-derived NO and polyamines on trophectoderm cell proliferation and IFNT production. Therefore, we conducted a series of experiments using an established ovine trophectoderm (oTr) cell line. These FIG. 1. Dose-dependent effects of arginine (Arg) on proliferation (A and B) and IFNT secretion (C-F) by oTr1 cells. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence in 24-well plates. After serum and insulin starvation for 24 h followed by additional deprivation of arginine for an extra 6 h, cells were cultured with the indicated doses of arginine. Cell numbers were determined after 48 h (A) or 96 h (B) of incubation. The total amount of IFNT secreted into culture medium per well at 48 h (C) or 96 h (D) was measured by RIA, whereas IFNT production per cell was calculated based on cell number per well at 48 h (E) and 96 h (F). Data are expressed as a percentage relative to nontreated control at 0 min. Effects of arginine dosage were significant (P , 0.05), and different superscript letters denote significant differences (P , 0.05) among treatment groups. All quantitative data are presented as means 6 SEM.
WANG ET AL. cells were treated with arginine, putrescine, and NO donors, as well as their associated inhibitors, to systematically assess effects of arginine on cell proliferation and IFNT production. Our results indicate that arginine-derived NO and polyamines increased oTr1 cell proliferation, whereas only argininederived polyamines stimulated IFNT production. These effects of arginine involved stimulation of the MTOR cell signaling pathway by tuberous sclerosis protein (TSC) 2 phosphorylation.
MATERIALS AND METHODS

Cell Culture
An established mononuclear oTr primary cell line (oTr1) from Day-15 sheep conceptuses was developed, propagated, and used in the present in vitro studies as described previously [25] [26] [27] [28] . The oTr1 cells exhibit numerous properties of oTr cells in vivo. The cells were cultured in complete medium (CM) (i.e., Dulbecco modified Eagle medium/Nutrient Mixture F-12; Gibco BRL, Grand Island, NY) with 10% fetal bovine serum (FBS; Gibco BRL), 50 U/ml penicillin, 50 lg/ml streptomycin, 0.1 mM each of ''nutritionally nonessential'' amino acids, 1 mM sodium pyruvate, 2 mM glutamine, and 4 lg/ ml insulin. The medium was replaced every 2 days. When the density of cells in the dishes reached about 80% confluence, subcultures of cells were prepared at a split at a ratio of 1:3, and frozen stocks of cells were preserved at each passage.
For the experiments, cultures of oTr1 cells (between passages 8 and 15) were grown in CM to 20%-30% confluence in a 24-well plate (Costar no. 3524; Corning, Corning, NY, USA), T25 flask (Costar no. 430372; Corning) or T75 flask (Costar no. 430641; Corning). Cells were serum-and insulin-starved for 24 h in customized medium, further deprived of arginine for an additional 6 h, and then treated with arginine, putrescine, S-nitroso-N-acetyl-DL-penicillamine (SNAP; N3398; Sigma-Aldrich, St. Louis, MO), diethylenetriamine (DETA; D185; Sigma-Aldrich), rapamycin (RAP; R8781; Sigma-Aldrich), Nxnitro-L-arginine methyl ester hydrochloride (L-NAME; N5751; NOS inhibitor; Sigma-Aldrich), and/or DL-a-difluoromethylornithine hydrochloride hydrate (DFMO; D193, ODC1 inhibitor; Sigma-Aldrich) at indicated concentrations in basal medium (BM; arginine-free customized medium containing 5% FBS and 1 ng/ml insulin), BM-I medium (customized medium containing 5% FBS and 1 ng/ml insulin), or BM-II medium (arginine-, glutamine-, and proline-free customized medium containing 5% FBS and 1 ng/ml insulin). For each experiment, the design was replicated in three independent experiments.
Proliferation Assay
The oTr1 cells were subcultured (1 3 10 4 cells/0.4 ml/well) in 24-well plates (Costar no. 3524; Corning) in CM until the monolayer reached 30% confluence and then switched to serum-and insulin-free customized medium. After starvation for 24 h, cells were further deprived of 1) serum, insulin, and arginine, or 2) serum, insulin, arginine, glutamine, and proline, for an additional 6 h. Cells (n ¼ 3 wells/treatment) were then cultured in 400 ll BM, BM-I, or BM-II medium at 0 min as a blank control, and then treated with arginine, L-NAME, DFMO, putrescine, RAP, SNAP, or DETA at selected doses. The medium was changed every 2 days, and treated cells were maintained for 2, 4, or 6 days. Cell numbers were determined as described previously [29] . Briefly, medium was removed from cells by vacuum aspiration, and cells were fixed in 50% ethanol for 30 min, followed by vacuum aspiration of the fixative. Fixed cells were stained with Janus Green B in PBS (pH 7.2) for 3 min at room temperature. The stain was immediately removed using a vacuum aspirator, and the whole plate was sequentially dipped into water and destained by gentle shaking. The remaining water was removed by shaking, after which stained cells were immediately lysed in 0.5 N HCl and absorbance readings were taken at 595 nm using a microplate reader. As described previously [29] , cell numbers were calculated from absorbance readings using the following formula: cell number ¼ (absorbance À 0.00462)/0.00006926. The entire experiment was repeated independently three times with different batches of oTr1 cells between passages 9 and 12.
Radioimmunoassay Analyses of IFNT
The amount of secreted IFNT in the culture medium was quantified using a radioimmunoassay (RIA) developed at Colorado State University using recombinant ovine IFNT (roIFNT) protein and anti-roIFNT polyclonal antibody (1:60 000), as reported previously [16] [17] [18] 30] . This RIA was optimized for detection of IFNT at a sensitivity of 0.1 ng/ml and a range of detection of 0.1-13 ng/ml. The intra-and interassay coefficients of variation were 6.2% and 4.0%, respectively.
Cell Count, Protein Extraction, and Total Protein per oTr1 Cell
Cells were detached from T25 flasks by incubating with 0.5% trypsinethylenediaminetetra-acetic acid (EDTA) solution (T4174; Sigma-Aldrich) at 378C for 2 min. After counting cell numbers using a hemocytometer, cell pellets were formed by centrifugation at 350 3 g for 4 min, washed several times with PBS, and then lysed by incubation in lysis buffer (1% Triton X-100, 0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris, 1 mM EDTA, 1 mM ethylene glycol tetra-acetic acid, 0.2 mM Na 3 VO 4 , 0.2 mM phenylmethylsulfonylfluoride, 50 mM NaF, 30 mM Na 4 P 2 O 7 , 1 lg/ml leupeptin, and 1 lg/ml pepstatin) for 30 min at 48C. Cell lysates were passed through a 26-gauge needle and clarified by centrifugation at 16 000 3 g for 15 min at 48C. The protein concentration was determined using the Bradford protein assay (BioRad, Hercules, CA) with bovine serum albumin as the standard. Finally, cell number divided by the total protein for each flask generated the total protein per oTr1 cell.
Quantitative Immunocytochemistry
The oTr1 cells were seeded onto Lab-Tek II 4-well chamber slides (154534; Sigma-Aldrich). After serum and insulin starvation for 24 h followed by additional deprivation of 1) arginine for an extra 6 h, or 2) arginine, glutamine, and proline for an extra 24 h, cells were then treated with: 1a) arginine (200 lM) in BM medium; 1b) arginine (200 lM) in the absence or presence of L-NAME (200 lM) or DFMO (5 mM) in BM medium; or 2) putresince (100 lM), SNAP (50 lM), or DETA (50 lM) in BM-II medium. After 12, 48, and 96 h, cells were fixed with À208C methanol for 10 min and rinsed with 0.02 M PBS containing 0.3% Tween (PBST) for 5 min. The cells were blocked in 5% normal goat serum for 2 h at room temperature, rinsed, and then immunofluorescence staining was performed using primary antibody overnight at 48C. Primary antibodies included rabbit anti-MTOR monoclonal IgG (no. 2983; Cell Signaling), rabbit anti-phospho-MTOR (p-MTOR) polyclonal IgG (no. 2971; Cell Signaling), and rabbit anti-phosphorylated TSC2 (p-TSC2) polyclonal IgG (no. 3615; Cell Signaling) at dilutions of 1:100, 1:50, and 1:100, respectively. Purified, nonrelevant rabbit IgG at the same effective concentration was substituted for the primary antibody as a negative control. Cells were then incubated with secondary antibody (i.e., Alexa Fluor 488 goat anti-rabbit IgG [A11008]; Invitrogen, Grand Island, NY) or Alexa Fluor 594 goat anti-rabbit IgG (A11037; Invitrogen) at a 1:250 dilution for 1 h at room temperature, and then rinsed in PBST and overlaid with Prolong Gold Antifade   FIG. 2 . Dose-dependent effects of arginine on total protein per oTr1 cell. The oTr1 cells (n ¼ 3 flasks) were seeded at 30% confluence in T25 flasks and then subjected to serum and insulin starvation for 24 h. After additional deprivation of arginine for an extra 6 h, cells were cultured with arginine at the indicated doses (0, 0.2, and 2 mM) for 5, 15, 30, and 60 min, and 12 and 48 h. At each time point, cell numbers were counted by hemocytometer and total protein extracted. Protein concentration was determined using the Bradford protein assay with bovine serum albumin as the standard. Effects of time, arginine dosage, and time-by-arginine dosage were significant (P , 0.01). Different superscript letters denote significant differences (P , 0.05) at the respective time points. All quantitative data are presented as means 6 SEM.
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0 ,6-diamidino-2-phenylindole (P36941; Invitrogen). Images were captured using a Zeiss Axioplan 2 microscope with an Axiocan HR camera and Axiovision 4 software (Carl Zeiss Microscopy, Thornwood, NY). All parameters during image acquisition were the same. Signals were quantified by Image J software (Version 1.47; National Institutes of Health) using standardized procedure, as described previously [31, 32] . Briefly, the cell region of interest (ROI; number of pixels for the selected cell) was defined by the Freehand selection tool. The next step was to split the image into the three color channels (RGB merge/split function) to gain one image per channel and then obtain the integrated density value (IDV; sum of the intensity of the pixels for the selected cell) of each molecule (i.e., MTOR, p-MTOR, and p-TSC2), depending on fluorescent color of secondary antibodies. In parallel, average signal per pixel for a region selected just beside the cell was measured as background signal for subtraction. Finally, the corrected total cell fluorescence (CTCF; arbitrary units) was calculated based on the following formula: CTCF ¼ IDV À (ROI 3 background signal), indicating the level of protein expression per cell analyzed. All quantitative data correspond to 10 fields per well and analyses of three wells.
Immuno-Slot Blot Analyses of IFNT
Secreted IFNT in culture medium was measured using a protein slot blot technique [33] . Protein concentration in the culture medium was determined using the Bradford protein assay with bovine serum albumin as the standard. Briefly, 300-lg samples of total protein were incubated at 968C for 10 min and slot blotted on to a nitrocellulose membrane using a Minifold I slot-blot array system (Sigma-Aldrich). Membranes were blocked in 5% fat-free milk in 20 mM Tris, 150 mM NaCl, pH 7.5, and 0.1% Tween-20 (TBST) for 2 h at room temperature, and then incubated with primary antibody at 48C overnight with gentle rocking. After three washes of 10 min each with TBST, the membranes were incubated at room temperature for 1 h with secondary antibody. The primary antibody, rabbit anti-roIFNT polyclonal IgG, and secondary antibody, horseradish peroxidase-linked anti-rabbit IgG (Cell Signaling, Danvers, MA), were used at dilutions of 1:15 000 and 1:20 000, respectively. The membranes were then washed with TBST as before, followed by development using enhanced chemiluminescence detection (SuperSignal West Pico, Thermo Fischer Scientific, Rockford, IL) according to the manufacturer's instructions. Multiple exposures of each slot blot were performed to ensure linearity of chemiluminescent signals. Protein slot blots were quantified by measuring the WANG ET AL.
intensity of light emitted from the immunoreactive slots under ultraviolet light using a ChemiDoc EQ system and Quantity One software (Bio-Rad). The signals were expressed as the percentage of immunoreactivity in the denatured state.
Analyses of Polyamines and Agmatine
Concentrations of polyamines (putrecine, spermidine, and spermine) and agmatine were determined in oTr1 cell lysates as well as BM medium using the modified procedures described previously [16] [17] [18] 34] . Briefly, oTr1 cells (1 3 10 6 cells) were seeded in a T75 flask, maintained overnight (;16 h) in CM, and then switched to serum-and insulin-free customized medium. After serum and insulin starvation for 24 h followed by extra deprivation of arginine for an additional 6 h, cells (n ¼ 3 flasks/treatment) were subcultured in the absence or presence of arginine (200 lM) with L-NAME (200 lM) and/or DFMO (5 mM) in 10 ml BM medium. The medium was removed at the end of a 48-h culture period, and the cell numbers were calculated by hemocytometer. Cell pellets from each T75 flask were collected and then acidified with 200 ll of 1.5 M HClO 4 and neutralized with 100 ll of 2 M K 2 CO 3 , while BM medium (100 ll) was acidified with 100 ll 1.5 M HClO 4 and neutralized with 50 ll of 2 M K 2 CO 3 (i.e., dilution factor of 2.5). The neutralized extracts were used for analysis by an HPLC method involving precolumn derivatization with ophthaldialdehyde (OPA) reagent. OPA reagent was prepared by dissolving 50 mg OPA and 50 mg N-acetyl-L-cysteine in 1.25 ml methanol, followed by addition of 11.2 ml of 0.04 M sodium borate buffer (pH 9.5), and 0.4 ml of Brij-35. The assay mixture contained 100 ll of sample and 100 ll of 1.2% benzoic acid (in 40 mM sodium borate [pH 9.5]). An aliquot (100 ll) of assay mixture was derivatized in an autosampler (model 712 WISP; Waters, Milford, MA) with 100 ll of 30 mM OPA reagent, and 100 ll of the derivatized mixture was injected in a Supelco 3-lm reversed-phase C 18 column (150 3 4.6 mm inside diameter; 58985; Sigma-Aldrich). Polyamines and agmatine were separated using a solvent gradient consisting of solution A (0.1 M sodium acetate, 2 mM SDS, 0.5% tetrahydrofuran, and 9% methanol [pH 7.2]) and solution B (methanol and 2 mM SDS). Putrescine, spermidine, spermine, and agmatine in samples were quantified on the basis of authentic standards.
Statistical Analyses
Normality of data and homogeneity of variance were tested using the Shapiro-Wilk test and Brown-Forsythe test, respectively, in SAS 8.1 (SAS Institute, Cary, NC). Data were analyzed by least-squares one-way ANOVA as well as the Fisher least significant difference as post hoc analysis, with each well identified as an experimental unit. All analyses were performed using SAS. Data are expressed as means 6 SEM, and values of P , 0.05 were considered significant.
RESULTS
Arginine Stimulates Proliferation and IFNT Production by oTr1 Cells in a Nonlinear, Dose-Dependent Manner
We first investigated the effects of arginine on oTr1 cell proliferation after 48 and 96 h of incubation. Arginine increased (P , 0.05) cell proliferation at both 48 and 96 h, and 0.2 mM was the optimal dose for maximum cell proliferation (by 2.0-fold at 48 h and 2.6-fold at 96 h; P , 0.05; Fig. 1, A and B) . As a measure of a functional effect of arginine on oTr1 cells, we assessed the total amount of IFNT (volume of culture medium 3 concentration of IFNT), the pregnancy recognition signal in ruminants, secreted by oTr1 cells into the culture medium after 48 and 96 h of incubation (Fig. 1, C and D) . In addition, IFNT secreted per cell was calculated based on cell numbers per well at 48 and 96 h (Fig.  1, E and F) . Effects of arginine dosage on IFNT production (per well and per cell bases) were significant at both 48 and 96 h, with the maximum production (0.009 ng IFNT/cell, increased by 3.1-fold; P , 0.05) at 0.2 mM of arginine (Fig.  1, C-F) .
Arginine Increased Total Protein in oTr1 Cells
Next, we determined total protein and associated numbers of oTr1 cells, and calculated total protein per cell at 0, 5, 15, 30, and 60 min, as well as 12 and 48 h of culture. Effects of time, arginine dosage, and time-by-arginine dosage were all significant (P , 0.01). For long-term incubation, arginine FUNCTIONAL ROLES OF ARGININE AND TROPHECTODERM ACTIVATION (0.2 and 2 mM) increased total protein per cell by 1.8-and 2.2-fold at 12 h, as well as 1.5-and 1.8-fold at 48 h, respectively (P , 0.05). However, there were no dosage-dependent effects of arginine between 0 and 60 min of culture (Fig. 2) .
Arginine Stimulates MTOR Signaling via Increased Phosphorylation of TSC2 in oTr1 Cells
We evaluated the abundance of total and p-MTOR as well as p-TSC2 using quantitative immunocytochemical analyses. After 12 and 48 h of incubation, the p-MTOR increased 4.3-and 4.9-fold (P , 0.0001) in the arginine-treated (0.2 mM) compared to the arginine-free control cells at 12 and 48 h, respectively (Fig. 3, A and C) . Total MTOR was not affected significantly by arginine treatment (Fig. 3, A and B) .
Moreover, as one of the regulators for MTOR cell signaling pathway, arginine treatment increased the abundance of p-TSC2 by 5.4-fold (P , 0.01) and 2.7-fold (P , 0.0001) compared with the control at 12 and 48 h of incubation, respectively (Fig. 4, A and B) .
Arginine Promotes oTr1 Cell Proliferation via Both Putrescine and NO Production
Next, inhibitors of NOS and ODC1 were employed to block the production of NO and polyamines, respectively, so that functional roles of arginine in stimulating oTr1 cell proliferation could be further dissected. After 48 and 96 h of incubation, cell proliferation was not inhibited by either L-NAME or DFMO, except at the higher concentrations, i.e., 400 (Fig. 5, A and B) , and 16.0% and 26.5% (P , 0.05) at 96 h of incubation (Fig. 5, C  and D) , respectively. After identifying the optimal dosage of inhibitors, we conducted the cell proliferation assay in L-NAME, DFMO, L-NAME þ DFMO, and inhibitor-free medium treated with or without arginine (Fig. 6) . Arginine increased proliferation of oTr1 cells by 1.9-and 2.4-fold (P , 0.01) in the absence of inhibitors as compared with the arginine-free controls at 48 and 96 h, respectively. When L-NAME (200 lM), DFMO (5 mM), and L-NAME þ DFMO were added, the effects of arginine on cell proliferation were reduced by 10.7%, 16.1%, and 22.3% (P , 0.05) at 48 h, as well as by 15.3%, 27.2%, and 39.1% (P , 0.05) at 96 h of incubation, respectively. However, even in the presence of L-NAME þ DFMO, arginine stimulated cell proliferation 1.5-fold (P , 0.05) as compared to the arginine-free controls at both 48 and 96 h of incubation.
Arginine Increases Intracellular Polyamines, but Decreases Intracellular Agmatine
To further determine whether the functional role of arginine in stimulating cell proliferation was mediated by polyamine synthesis, and whether an alternative arginine-agmatineputrescine pathway existed for polyamine synthesis in oTr1 cells, intracellular putrescine, spermidine, spermine, and agmatine were analyzed when inhibitors of NOS and ODC1 were employed to block the production of NO and ornithinederived polyamines, respectively. After 48 h of incubation, arginine at a physiological level increased intracellular putrescine, spermidine, and spermine by 5.0-, 1.6-, and 1.3-fold (P , 0.05), respectively, compared with the arginine-free controls (Fig. 7, A-C) . However, when L-NAME (200 lM), DFMO (5 mM), or L-NAME þ DFMO was added to culture medium, the arginine-driven increases in intracellular polyamines were reduced (P , 0.05) by 82.7%, 89.3%, and 89.1% for putrescine, 70.9%, 81.0%, and 80.9% for spermidine, and 64.3%, 72.3%, and 68.5% for spermine, respectively, as compared to the respective arginine groups (Fig. 7, A-C) . Even in comparison to arginine-free controls, intracellular spermidine still decreased by 54.2%, 70.1%, and 69.9% (P , 0.05), and spermine decreased by 55.3%, 65.4%, and 60.5% (P , 0.05) in arginine þ L-NAME, arginine þ DFMO, and arginine þ L-NAME þ DFMO groups, respectively (Fig. 7, A-C) . Interestingly, arginine at a physiological level decreased intracellular agmatine by 26.5% (P , 0.05), compared to the arginine-free control, and intracellular agmatine was further decreased by 78.4%, 79.1%, and 83.2% (P , 0.05) when L-NAME (200 lM), DFMO (5 mM), and L-NAME þ DFMO were added, respectively (Fig. 7D) . In BM medium that contained 5% FBS, putrescine, spermidine, and spermine were undetectable (,0.5 lM), whereas the concentration of agmatine was 18.3 6 3.9 lM (Fig. 7E) .
Putrescine Stimulates oTr1 Cell Proliferation in a Nonlinear, Dosage-Dependent Manner
We next evaluated direct effects of putrescine on oTr1 cell proliferation at 48, 96, and 144 h of incubation. Putrescine increased oTr1 cell proliferation in a nonlinear dosagedependent manner. Effects of putrescine dosage on cell proliferation were all significant (P , 0.01) at each of the time points in both BM-I medium (customized medium that contained 5% FBS and 1 ng/ml insulin; Fig. 8A ) and in BM-II medium (arginine-, glutamine-, and proline-free customized medium that contains 5% FBS and 1 ng/ml insulin; Fig. 8B ). However, the fold changes in cell proliferation were less among putrescine dosages in BM-I medium at each time point, due to the presence of arginine, glutamine, and proline, all of which are potential precursors for polyamine synthesis (Fig.  8A) . Alternatively, by incubating oTr1 cells in BM-II medium that lacked arginine, glutamine, and proline, greater fold 
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changes in oTr1 cell proliferation were apparent (Fig. 8B) . The optimal doses of putrescine ranged from 50 to 250 lM, which increased oTr1 cell proliferation by 1.5-, 1.8-, and 2.0-fold (P , 0.05) at 48, 96, and 144 h of incubation, respectively (Fig.  8B) . Interestingly, after 48 h of culture in putrescine-free medium, cell numbers decreased significantly as compared to cell numbers at time 0 (Fig. 8B) , which suggests the indispensable role of polyamines in cell proliferation.
NO Donor Stimulates oTr1 Cell Proliferation in a Quadratic Dosage-Dependent Manner
To evaluate the direct effects of NO on cell proliferation, oTr1 cells were treated with NO donors (i.e., SNAP and DETA). SNAP and DETA had similar effects on proliferation of oTr1 cells, which increased 1.6-and 2.9-fold (P , 0.01) after 48 and 96 h of incubation, respectively (Fig. 9) .
FIG. 7.
Arginine increases intracellular polyamines, but decreases agmatine transport. The oTr1 cells (n ¼ 3 flasks) were seeded at 30% confluence in T75 flasks. After serum and insulin starvation for 24 h and an extra 6 h of arginine deprivation, cells were cultured in the absence or presence of arginine (200 lM) with L-NAME (200 lM) and/or DFMO (5 mM). Cell numbers, as well as intracellular polyamines and agmatine, were determined after 48 h of incubation (A-D). Polyamines and agmatine in BM medium were also determined as reference (E). Different superscript letters denote significant differences (P , 0.05). All quantitative data are presented as means 6 SEM. ND, not detected.
Arginine Stimulates Secretion of IFNT by oTr1 Cells Preferentially via Putrescine Rather than NO
Effects of doses and time (48 and 96 h of incubation) of arginine on IFNT production by oTr1 cells were evaluated by immune-slot blot analysis. Arginine increased (P , 0.01) IFNT secretion in a nonlinear dosage-dependent manner with the maximum production at 0.2-1 mM arginine at both 48 and 96 h (Fig. 10) . To further evaluate whether putrescine and/or NO (products of arginine metabolism) stimulate IFNT secretion by oTr1 cells, the cells were treated with putrescine and NO donors (SNAP and DETA), and amounts of IFNT secreted into the culture medium after 48, 96, and/or 144 h of incubation were determined (Figs. 11 and 12 ). Putrescine increased IFNT secretion by 1.5-, 1.6-, and 2.2-fold (P , 0.01) after 48, 96, and 144 h of incubation in BM-II medium (Fig. 11, D-F) , respectively, whereas an increase of 1.3-fold (P , 0.01) was detected only after 48 h in cells cultured in BM-I medium (Fig. 11, A-C) . However, there was no effect (P . 0.05) of NO donors on secretion of IFNT by oTr1 cells in either culture medium after 48 and 96 h of incubation (Fig.  12) .
FIG. 8. Dose-dependent effects of putrescine on proliferation of oTr1 cells. The oTr1 cells (n ¼ 4 wells) were seeded at 30% confluence in 24-well plates and underwent serum and insulin starvation for 24 h. After additional deprivation of arginine, glutamine, and proline for an extra 24 h, the cells were cultured in (A) BM-I medium (customized medium containing 5% FBS and 1 ng/ml insulin) or (B) BM-II medium (arginine-, glutamine-, and proline-free customized medium containing 5% FBS and 1 ng/ml insulin, and treated with the indicated doses of putrescine. Cell numbers were determined after 48, 96, and 144 h of incubation. Data are expressed as a percentage relative to nontreated control at 0 min. The effects of putrescine dosage were significant (P , 0.01), and different superscript letters denote significant differences (P , 0.05) among groups. All quantitative data are presented as means 6 SEM.
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Arginine and Putrescine Stimulates oTr1 Cell Proliferation and Secretion of IFNT via MTOR Signaling Pathway
To further validate that the effects of arginine, as well as putrescine, on cell proliferation and IFNT secretion by oTr1 cells were triggered by MTOR cell signaling pathway, RAP was employed in the following two experiments. After 12, 48, and 96 h of incubation, arginine increased oTr1 cell proliferation by 1.4-, 1.9-, and 2.2-fold (P , 0.05), whereas putrescine increased oTr1 cell proliferation by 1.2-, 1.4-, and 1.6-fold (P , 0.05), respectively (Fig. 13, A-C) . When RAP was added, both arginine-and putrescine-driven proliferation of oTr1 cells were completely inhibited (P , 0.05; Fig. 13 , A-C). Next, effects of arginine and putrescine on IFNT production by oTr1 cells in the presence or absence of RAP were evaluated by immune-slot blot analysis after 12, 48, and 96 h of incubation (Fig. 13, D-F) . Both arginine and putrescine increased IFNT secretion by 1.7-and 1.6-fold (P , 0.05), respectively, at both 48 and 96 h of incubation (Fig. 13, E and  F) . When RAP was added, both arginine-and putrescinedriven stimulations of IFNT production were completely inhibited (P , 0.05; Fig. 13, E and F) . However, no differences (P . 0.05) in IFNT production were observed among all treated groups at 12 h (Fig. 13D) .
Arginine Activates the TSC2-MTOR Signaling Cascade in oTr1 Cells via Products of Its Metabolism as Putrescine and NO
Quantitative immunocytochemical analyses were used to evaluate the abundance of MTOR, p-MTOR, and p-TSC2 in oTr1 cells treated with 1) arginine in the absence or presence of an inhibitor of NOS (L-NAME) or ODC1 (DFMO) or 2) putrescine or NO donors (SNAP and DETA). In comparison to the arginine-free control, arginine increased (P , 0.01) p-MTOR 6.8-and 2.9-fold, and p-TSC2 7.0-and 4.0-fold after 48 and 96 h of incubation, respectively (Fig. 14, A and B) . When L-NAME (200 lM) was added, arginine-stimulated increases in p-MTOR and p-TSC2 were reduced (P , 0.01) by 56.1% and 71.0% at 48 h, and 57.1% and 70.8% at 96 h, whereas, when DFMO (5 mM) was added, arginine-stimulated increases in p-MTOR and p-TSC2 were reduced (P , 0.01) by 52.8% and 62.8% at 48 h, and 68.9% and 69.1% at 96 h (Fig.  14, A and B) . Total MTOR was not different (P . 0.05) among the treatment groups at the respective time points. In addition, after 48 h of incubation, putrescine, SNAP, and DETA increased (P , 0.001) p-MTOR by 4.3-, 3.0-, and 4.3-fold, and p-TSC2 by 12.5-, 5.9-, and 6.5-fold, respectively (Fig. 15,  A and B) . After 96 h, putrescine, SNAP, and DETA increased p-MTOR by 3.5-, 2.9-, and 2.4-fold (P , 0.001), and p-TSC2 by 2.7-, 2.1-, and 2.5-fold (P , 0.0001), respectively (Fig. 15,  A and B) .
DISCUSSION
During the peri-implantation period of pregnancy, cells of conceptuses of ungulates and cetaceans undergo proliferation, migration, and rapid cytoskeleton reorganization for rapid elongation and implantation that requires orchestrated conceptus-uterine interactions (i.e., pregnancy recognition signaling by conceptuses, implantation and response to components of histotroph for uterine epithelia). Of those nutrients provided in histotroph, arginine is one of the most intensively studied multifunctional amino acids that enhances implantation and embryonic survival in mice, rats, sheep, and pigs [9, 19-22, 28, 35] . In vivo deprivation of arginine or polyamines causes developmental retardation of ovine conceptuses and their secretion of IFNT [16, 18] , whereas an NO deficiency in vivo results in small, but elongated, conceptuses that secrete normal amounts of IFNT [17] . However, the mechanisms whereby products of arginine metabolism, NO and polyamines, support conceptus growth and survival and secretion of IFNT production have not been systematically studied. Therefore, the present study examined functional roles of arginine mediated via NO and/or polyamines on trophectoderm cell proliferation and IFNT production using an established oTr1 cell line.
The results of this study provide the first in vitro evidence that arginine increases oTr1 cell proliferation via production of NO and polyamines in a dose-dependent manner, and that FIG. 9. Dose-dependent effects of NO donor on proliferation of oTr1 cells. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence in 24-well plates and underwent serum and insulin starvation for 24 h. After additional deprivation of arginine for an extra 6 h, the cells were treated with the indicated doses of SNAP (A) or DETA (B) in BM medium. Cell numbers were determined after 48 and 96 h of incubation. Data are expressed as a percentage relative to nontreated control at 0 min. Dosage effects of both SNAP and DETA were significant (P , 0.01) at 48 and 96 h, and different superscript letters denote significant differences (P , 0.01) among groups. All quantitative data are presented as means 6 SEM.
putrescine is a metabolically important product of arginine that stimulates IFNT production by oTr cells. The effects of arginine involve stimulation of the MTOR cell signaling pathway and TSC2 phosphorylation to remove inhibition of MTOR cell signaling. First, arginine increased oTr1 cell proliferation as well as IFNT production in a nonlinear dosagedependent manner (Fig. 1) , with maximum effects on cell proliferation and IFNT production at 0.2 mM arginine (Fig. 1,  C-F) . These results indicate that arginine, a nutritionally essential amino acid for gestating mammals [36] , is critical for survival and proliferation, as well as IFNT production by trophectoderm cells for pregnancy recognition signaling in ruminants.
Cell proliferation, defined as an increase in cell numbers by cell division, consists of four major phases, G 1 , S, G 2 , and M phases, whereby significant protein synthesis occurs during the G 2 phase. Thus, we determined the average amount of total protein per cell in real time following treatment of oTr1 cells with arginine (Fig. 2) . The increase in total protein per cell suggests that arginine (0.2 and 2 mM) stimulates protein synthesis in oTr1 cells, which is consistent with results from previous studies with other cell types [28, [37] [38] [39] . Many cell signaling molecules can convey information to cells to effect cell proliferation. MTOR, a serine/threonine kinase, is one of the most important proteins that regulate translation and cell division [39, 40] . Previous studies have shown that MTOR complex 1 (MTORC1) is key to the nutrient-sensing signaling network that controls cell metabolism [41] , and arginine enhances protein synthesis via an MTOR-RPS6K-RPS6 signaling cascade in both porcine and oTr cells [28, 37] . However, the upstream regulator driven by arginine to activate MTOR signaling in trophectoderm cells is unknown. Therefore, we investigated the expression levels of total and p-MTOR as well as phosphorylation of TSC2 in oTr1 cells treated with arginine (Figs. 3 and 4) . TSC2 protein contains a GTPase-activating protein domain that stimulates GTPase   FIG. 10 . Dose-dependent effects of arginine on the IFNT production by oTr1 cells. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence in 24-well plates and underwent serum and insulin starvation for 24 h. After additional deprivation of arginine for an extra 6 h, the cells were treated with indicated doses of arginine for 48 h (A) and 96 h (B). At each time point, the total amount of IFNT secreted into culture medium per well was measured by immuneslot blot analyses. Data are expressed as a percentage relative to the arginine-free control culture at each time point. The effects of arginine dosage were significant (P , 0.01) at 48 and 96 h, and different superscript letters denote significant differences (P , 0.05) among groups. All quantitative data are presented as means 6 SEM.
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activity of the small GTPase Rheb [42] [43] [44] [45] . Since Rheb in its GTP-bound form is an activator of MTORC1 [43] , TSC2 is inhibitory to the MTORC1 signaling cascade, and phosphorylation of TSC2 removes the inhibition. Consequently, increases in p-MTOR as well as p-TSC2 suggest that arginine activates the MTOR signaling pathway by increasing phosphorylation of TSC2 in oTr1 cells.
A dramatic increase of arginine in the uterine lumen as well as in fetal fluids is associated with high rates of NO and polyamine biosynthesis when trophectoderm growth is most rapid during early pregnancy in mammals [9, [46] [47] [48] [49] . To better dissect the functional role of arginine on cell proliferation, we recruited L-NAME and DFMO, the NOS and ODC1 inhibitors that block production of NO and putrescine, respectively. Inhibition efficiency and toxicity tests demonstrated that 200 lM L-NAME or 5 mM DFMO effectively inhibited oTr1 cell proliferation, whereas 400 lM L-NAME or 10 mM DFMO was toxic to oTr1 cells. In the present study, optimal doses of L-NAME, DFMO, and L-NAME þ DFMO double inhibitors resulted in the most substantial decreases (22.3% at 48 h and 39.1% at 96 h; P , 0.05) in oTr1 cell proliferation, whereas L-NAME caused the lowest decrease (10.7% at 48 h and 15.3% at 96 h; P , 0.05), and effects of DFMO were intermediate (16. 1% at 48 h and 27.2% at 96 h; P , 0.05; see Fig. 6 ). These results suggest that both arginine-dependent NO and polyamine synthesis increase proliferation of oTr1 cells; however, putrescine (polyamines) was more stimulatory than NO. Moreover, cell numbers were 1.5-fold greater than for the arginine-free control groups at both 48 and 96 h in the presence of L-NAME þ DFMO, which suggests that: 1) arginine, per se, is a growth factor that cooperatively stimulates cell proliferation or 2) the activation of alternative arginine-agmatineputrescine pathway for polyamine biosynthesis rescued cells from polyamine deficiency [18] . The first hypothesis is substantiated by the results that L-NAME and/or DFMO reduced concentrations of polyamines in oTr1 cells (Fig. 7, A-D) . However, agmatine concentrations decreased in the arginine-treated group as compared with the arginine-free control. Additionally, the presence of approximately 20 lM agmatine in the BM containing 5% FBS suggests that arginine FIG. 11 . Dose-dependent effects of putrescine on IFNT production by oTr1 cells. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence in 24-well plates and underwent serum and insulin starvation for 24 h. After additional deprivation of arginine (A-C) or arginine, glutamine, and proline (D-F) for an extra 24 h, the cells were treated with the indicated doses of putrescine for 48 h (A and D), 96 h (B and E), and 144 h (C and F). At each time point, the total amount of IFNT secreted into the culture medium was measured by immune-slot blot analyses. Data are expressed as a percentage relative to control (0 lM putrescine) cultures at each time point. The effects of putrescine dosage were significant (P , 0.01) after 48, 96, and 144 h of incubation in BM-II medium, whereas the effect of putrescine dosage was only significant (P , 0.01) after 48 h of incubation in the BM-I medium. Different superscript letters denote significant differences (P , 0.05) among all groups. All quantitative data are presented as means 6 SEM.
may inhibit transport of extracellular agmatine into oTr1 cells (Fig. 7, D and E) .
To validate the hypothesis that arginine-dependent NO and polyamines stimulates cell proliferation, we investigated direct effects on cell proliferation. In the presence of arginine, glutamine, and proline, exogenous putrescine induced significant increases in cell proliferation, but fold changes were not physiologically significant. This is because endogenous polyamines are derived from precursors (arginine, glutamine, and proline) present in the culture medium. However, cells cultured in medium free of arginine, glutamine, and proline responded to putrescine in a dosage-dependent manner, with maximum fold changes of 1.5-, 1.8-, and 2.0-fold at 48, 96, and 144 h, respectively (Fig. 8B) . Interestingly, the number of oTr1 cells decreased significantly after 48 h of culture in putrescinefree medium, indicating that polyamines play an indispensable role in stimulating cell proliferation (Fig. 8) . Meanwhile, increases in oTr1 cells treated with either SNAP or DETA also demonstrate that NO contributes to increases in proliferation of oTr1 cells (Fig. 9) . These findings support the notion that mammals have dietary requirements for arginine to optimize growth and reproduction [8, 50] .
Successful establishment and maintenance of pregnancy requires appropriate pregnancy recognition signaling from healthy developed conceptuses [51, 52] . IFNT, the pregnancy recognition signal in ruminants, is produced and secreted by mononuclear trophectoderm cells from Days 10 to 21, with the maximum production occurring between Days 14 and 16 of pregnancy [51, 52] . Of the nutrients present in histotroph, arginine increases dramatically between Days 10 and 15 of pregnancy to support growth and development of the conceptus since it is the precursor for production of NO and polyamines [11, 28, 35] . Our previous in vivo knockdown model revealed that deprivation of both arginine and polyamine production in ovine conceptuses results in a significant decreases in IFNT production, whereas no such effect occurred in NO-deficient conceptuses. In the current study, therefore, oTr1 cells were treated with arginine, putrescine, NO donors (SNAP and DETA), or RAP, and IFNT production was determined to understand the relationship between multifunctional arginine and IFNT production (Figs. 10-13 ). Both arginine and putrescine stimulated IFNT production by oTr1 cells, whereas neither SNAP nor DETA affected IFNT production. Moreover, in the presence of RAP, the stimulatory effects of arginine and putrescine on IFNT production, as well as cell proliferation, were completely inhibited. These results indicate that arginine stimulates IFNT production by oTr1 cells mainly through polyamine synthesis instead of NO production. The stimulatory effects of arginine on IFNT production and cell proliferation result from activation of the TSC2-MTOR signaling cascade, since MTOR up-regulates expression of MyD88 and IRF7 for cell signaling for induction of expression of type I IFNs, such as IFNT [53] . In turn, IFNT induces expression of cationic amino acid transporters in uterine LE and sGE in vivo to increase transport of arginine into the uterine lumen, which then acts on trophectoderm cells to increase interactions between MTOR, MyD88, and TLR7/TLR8 to further increase expression of IFNT mRNA during the peri-implantation period of pregnancy [54, 55] .
Finally, to clarify whether TSC2-MTOR activation and production of NO and polyamines are parallel pathways activated by arginine, we investigated effects of arginine on the abundance of MTOR, p-MTOR, and p-TSC2 in the presence of an inhibitor of NOS (L-NAME) and an inhibitor of FUNCTIONAL ROLES OF ARGININE AND TROPHECTODERM ACTIVATION ODC1 (DFMO) (Fig. 14) . We also investigated direct effects of polyamines and NO donors on the abundance of MTOR, p-MTOR, and p-TSC2 to clarify whether NO and polyamines have their effects via TSC2-MTOR activation (Fig. 15) . The results suggest that arginine activates the TSC2-MTOR signaling cascade via both of its products of metabolism (i.e., NO and polyamines). We demonstrated that polyamines, but not NO, stimulate IFNT production by oTr1 cells and that the FIG. 13 . Arginine and putrescine stimulates oTr1 cell proliferation and secretion of IFNT via the MTOR signaling pathway. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence in 24-well plates and underwent serum and insulin starvation for 24 h. After additional deprivation of arginine, glutamine, and proline for an extra 24 h, the cells were cultured in BM-II medium, and treated with the indicated doses of arginine, putrescine, and/or RAP. Cell numbers were determined after 12, 48, and 96 h of incubation (A-C). The total amount of IFNT secreted into culture medium was then measured by immune-slot blot analyses after 12, 48, and 96 h of incubation (D-F). Data are expressed as a percentage relative to nontreated control at 0 min for proliferation assay, and to nontreated control at 12, 48, or 96 h for immune-slot blot analyses. Different superscript letters denote significant differences (P , 0.05) among groups. All quantitative data are presented as means 6 SEM.
effect of polyamines on IFNT production can be inhibited by RAP. We also found that both NO and polyamines induce activation of TSC2-MTOR, which suggests that activation of MTOR is necessary, but not sufficient to account for the finding that polyamines, but not NO, stimulate IFNT production. Research beyond the scope of this study is necessary to understand the differential effects of NO and polyamines on components of the pathway for stimulation of secretion of IFNT.
In summary, arginine added into culture medium at physiological concentrations stimulates oTr1 cell proliferation and protein synthesis via its metabolism to NO and polyamines, but putrescine in particular. Arginine also stimulates IFNT production exclusively via polyamine biosynthesis. These beneficial effects of arginine achieved via stimulation of the MTOR cell signaling pathway by TSC2 phosphorylation provide important insights into understanding orchestrated events between the conceptus and uterus during the peri-implantation period of pregnancy. Furthermore, this study demonstrates the potential role of arginine as a dietary supplement to improve conceptus survival, growth, and development, thereby eventually increasing successful outcomes of pregnancy [56, 57] . Future studies will address whether there are synergistic effects of arginine with other components in the histotroph, such as secreted phosphoprotein 1, on proliferation, migration, attachment, and signal transduction of peri-implantational conceptus in mammals.
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FIG. 14. Arginine (Arg) activates the TSC2-MTOR signaling cascade in oTr1 cells via products of its metabolism to putrescine and NO. The oTr1 cells (n ¼ 3 wells) were seeded at 30% confluence onto Lab-Tek II four-well chamber slides. After serum and insulin starvation for 24 h followed by an additional deprivation of arginine for 6 h, cells were treated with arginine (200 lM) in the absence or presence of L-NAME (200 lM) or DFMO (5 mM). Quantitative immunocytochemical analyses demonstrated increased abundance of p-TSC2 and p-MTOR in oTr1 cells treated with arginine for 48 and 96 h, whereas L-NAME or DFMO inhibited such increases in p-TSC2 and p-MTOR at 48 and 96 h (A and B). Total MTOR was not different among the treatment groups (A and B). a.u., arbitrary units. Width of field, 220 lm. Data are presented as means 6 SEM. Different superscript letters denote significant differences (P , 0.05) at each time point. For clarity, global contrast adjustments were processed uniformly for each image of total MTOR, p-MTOR, and p-TSC2 at the respective time points.
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